Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website http://www.jocmr.org

Original Article

Volume 3, Number 3, June 2011, pages 124-131


Clinical Comparison of Conventional Testicular Sperm Extraction and Microdissection Techniques for Non-Obstructive Azoospermia

Tables

Table 1. A Comparison of Baseline Data Between Conventional Testicular Sperm Extraction (TESE) and Microdissection TESE Groups
 
ConventionalMicrodissectionP Value
Testing by Mann Whitney and chi-square
Age35.4 ± 7.134.8 ± 8.50.4
Mean FSH (IU/L)16.7 ± 14.219.7 ± 12.50.06
FSH (IU/L), n (%)0.13
  < 2452 (76.5%)42 (64.6%)
  ≥ 2416 (23.5%)23 (35.4%)
LH (IU/L)11.1 ± 8.011.0 ± 7.60.8
TEST (ng/ml)3.9 ± 2.24.3 ± 2.20.3
PROL (ug/L)8.7 ± 4.18.7 ± 2.90.4
Testicular volume (ml)11.9 ± 4.611.8 ± 4.11.0
Patients with varicocele, n (%)9 (13.2)10 (15.4)0.7
Patients after orchidopexy, n (%)3 (4.4)3 (4.6)1.0
Histopathological diagnosis, n (%)0.7
  Hypospermatogenesis25 (36.8)28 (43.1)
  Maturation arrest11 (16.2)11 (16.9)
  Sertoli cell-only syndrome32 (47.1)26 (40.0)

 

Table 2. Sperm Retrieval Rate According to the Class of Plasma FSH Concentration, Testicular Volume and Histopathological Diagnosis
 
ConventionalMicrodissectionP value
H: hypospermatogenesis; MA: maturation arrest; SCOS: Sertoli cell-only syndrome; *: statistically significant
FSH (IU/L)< 2425/52 (48.1%)28/42 (66.7%)0.07
≥ 241/16 (6.2%)9/23 (39.1%)0.02*
Testicular volume (ml)≤ 83/18 (16.7%)5/17 (29.4%)0.4
9 - 128/26 (30.8%)15/27 (55.6%)0.07
> 1215/24 (62.5%)17/21 (81.0%)0.1
PathologyH21/25 (84.0%)26/28 (92.9%)0.3
MA3/11 (27.3%)4/11 (36.4%)0.6
SCOS2/32 (6.2%)7/26 (26.9%)0.03*
Total26/68 (38.2%)37/65 (56.9%)0.03*

 

Table 3. Assessment of Success of Both Micro TESE and Conventional TESE Using Binary Logistic Regression
 
FactorMicrodissectionConventionalTotal
ORCI (95%)P-valueORCI (95%)P-valueORCI (95%)P-value
*: statistically significant
Age1.010.96 - 1.080.670.970.90 - 1.040.370.990.95 - 1.040.73
Histopathology
   HS111
   MA0.040.01 - 0.290.001*0.070.01 - 0.390.002*0.060.02 - 0.21< 0.001*
   SCO0.030.01 - 0.15< 0.001*0.010.002 - 0.08< 0.001*0.020.01 - 0.07< 0.001*
Testicular volume1.311.08 - 1.590.006*1.241.07 - 1.430.004*1.251.12 - 1.40< 0.001*
Testicular volume range
  ≤ 8111
  9 - 123.000.83 - 10.900.102.220.50 - 9.890.302.590.99 - 6.740.05*
  > 1210.22.26 - 46.10.003*8.331.88 - 37.00.005*8.313.00 - 23.01< 0.001*
FSH0.960.92 - 1.000.05*0.820.75 - 0.90< 0.001*0.930.90 - 0.96< 0.001*
FSH range
  < 24111
  ≥ 240.320.11 - 0.920.04*0.070.01 - 0.590.010.270.12 - 0.610.002*
LH0.990.93 - 1.050.720.730.61 - 0.870.001*0.920.87 - 0.970.003*
Testosterone1.060.84 - 1.330.641.180.94 - 1.480.161.130.96 - 1.320.14
Prolactin0.940.79 - 1.110.461.010.89 - 1.130.930.980.89 - 1.080.73

 

Table 4. Assessment of Success of Microdissection TESE Compared to Conventional TESE Using Binary Logistic Regression
 
Microdissection TESE Combined With Other FactorsORCI (95%)P-value
*: statistically significant
Alone2.141.07 - 4.270.03*
Adjusted to FSH3.541.55 - 8.080.003*
Adjusted to Testicular Volume2.501.17 - 5.350.02*
Adjusted to Histopathology2.961.10 - 7.990.03*
Adjusted to FSH and Testicular Volume3.681.53 - 8.860.004*
Adjusted to FSH and Histopathology3.471.25 - 9.600.01*
Adjusted to Testicular Volume and Histopathology3.001.11 - 8.100.03*
Adjusted to FSH, Testicular Volume and Histopathology3.561.28 - 9.920.02*